99 related articles for article (PubMed ID: 9127631)
41. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
[TBL] [Abstract][Full Text] [Related]
42. Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation.
Sidle A; Palaty C; Dirks P; Wiggan O; Kiess M; Gill RM; Wong AK; Hamel PA
Crit Rev Biochem Mol Biol; 1996 Jun; 31(3):237-71. PubMed ID: 8817077
[TBL] [Abstract][Full Text] [Related]
43. p53-mediated accumulation of hypophosphorylated pRb after the G1 restriction point fails to halt cell cycle progression.
Linke SP; Harris MP; Neugebauer SE; Clarkin KC; Shepard HM; Maneval DC; Wahl GM
Oncogene; 1997 Jul; 15(3):337-45. PubMed ID: 9233768
[TBL] [Abstract][Full Text] [Related]
44. Combinatorial roles for pRB, p107, and p130 in E2F-mediated cell cycle control.
Classon M; Salama S; Gorka C; Mulloy R; Braun P; Harlow E
Proc Natl Acad Sci U S A; 2000 Sep; 97(20):10820-5. PubMed ID: 10995475
[TBL] [Abstract][Full Text] [Related]
45. Cloning and characterization of murine p16INK4a and p15INK4b genes.
Quelle DE; Ashmun RA; Hannon GJ; Rehberger PA; Trono D; Richter KH; Walker C; Beach D; Sherr CJ; Serrano M
Oncogene; 1995 Aug; 11(4):635-45. PubMed ID: 7651726
[TBL] [Abstract][Full Text] [Related]
46. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein.
Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL
Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505
[TBL] [Abstract][Full Text] [Related]
47. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
Hu X; Cress WD; Zhong Q; Zuckerman KS
Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
[TBL] [Abstract][Full Text] [Related]
48. RhoE inhibits cell cycle progression and Ras-induced transformation.
Villalonga P; Guasch RM; Riento K; Ridley AJ
Mol Cell Biol; 2004 Sep; 24(18):7829-40. PubMed ID: 15340047
[TBL] [Abstract][Full Text] [Related]
49. Cell cycle dependent effects of u.v.-radiation on p53 expression and retinoblastoma protein phosphorylation.
Haapajärvi T; Kivinen L; Pitkänen K; Laiho M
Oncogene; 1995 Jul; 11(1):151-9. PubMed ID: 7624123
[TBL] [Abstract][Full Text] [Related]
50. The helix-loop-helix protein Id-1 and a retinoblastoma protein binding mutant of SV40 T antigen synergize to reactivate DNA synthesis in senescent human fibroblasts.
Hara E; Uzman JA; Dimri GP; Nehlin JO; Testori A; Campisi J
Dev Genet; 1996; 18(2):161-72. PubMed ID: 8934878
[TBL] [Abstract][Full Text] [Related]
51. p27kip1-independent cell cycle regulation by MYC.
Berns K; Martins C; Dannenberg JH; Berns A; te Riele H; Bernards R
Oncogene; 2000 Oct; 19(42):4822-7. PubMed ID: 11039898
[TBL] [Abstract][Full Text] [Related]
52. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation.
Albino AP; Juan G; Traganos F; Reinhart L; Connolly J; Rose DP; Darzynkiewicz Z
Cancer Res; 2000 Aug; 60(15):4139-45. PubMed ID: 10945621
[TBL] [Abstract][Full Text] [Related]
53. Tumor suppressor proteins as regulators of cell differentiation.
Li ZR; Hromchak R; Mudipalli A; Bloch A
Cancer Res; 1998 Oct; 58(19):4282-7. PubMed ID: 9766653
[TBL] [Abstract][Full Text] [Related]
54. Three-dimensional matrix suppresses E2F-controlled gene expression in glomerular mesangial cells.
Tsuboi N; Yoshida H; Kawamura T; Furukawa Y; Hosoya T; Yamada H
Kidney Int; 2000 Apr; 57(4):1581-9. PubMed ID: 10760093
[TBL] [Abstract][Full Text] [Related]
55. A cyclin-dependent kinase inhibitor, butyrolactone I, inhibits phosphorylation of RB protein and cell cycle progression.
Kitagawa M; Higashi H; Takahashi IS; Okabe T; Ogino H; Taya Y; Hishimura S; Okuyama A
Oncogene; 1994 Sep; 9(9):2549-57. PubMed ID: 8058318
[TBL] [Abstract][Full Text] [Related]
56. Cell cycle control by p53 in normal (3T3) and chemically transformed (Meth A) mouse cells. I. Regulation of p53 expression.
Steinmeyer K; Maacke H; Deppert W
Oncogene; 1990 Nov; 5(11):1691-9. PubMed ID: 2267135
[TBL] [Abstract][Full Text] [Related]
57. The retinoblastoma gene product is reversibly dephosphorylated and bound in the nucleus in S and G2 phases during hypoxic stress.
Amellem O; Stokke T; Sandvik JA; Pettersen EO
Exp Cell Res; 1996 Aug; 227(1):106-15. PubMed ID: 8806457
[TBL] [Abstract][Full Text] [Related]
58. [Dependence of the process leading to phosphorylation of retinoblastoma protein (pRb) on the status of the actin cytoskeleton].
Barkan RS; Kudriavtseva NV; Reshetnikova GF
Tsitologiia; 1998; 40(2-3):172-7. PubMed ID: 9610482
[TBL] [Abstract][Full Text] [Related]
59. Mediation of chondrogenic and osteogenic differentiation by an interferon-inducible p202 protein.
Kong L; Liu CJ
Cell Mol Life Sci; 2008 Nov; 65(21):3494-506. PubMed ID: 18791844
[TBL] [Abstract][Full Text] [Related]
60. Activation of multiple growth regulatory genes following inducible expression of IRF-1 or IRF/RelA fusion proteins.
Nguyen H; Lin R; Hiscott J
Oncogene; 1997 Sep; 15(12):1425-35. PubMed ID: 9333018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
